Profit setback for Simcere Pharma in novel drugs quest
The pharmaceutical company’s profits have been buffeted by erratic returns on an equity stake in a fellow developer of innovative drugs Key Takeaways: Simcere Pharmaceutical holds a 9% stake in…
FAST NEWS: Simcere’s Covid drug trial shows promising results
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced Thursday that newly published results of a Phase 2/3 clinical study for its innovative drug, Xiannuoxin, for the treatment of adult patients…
FAST NEWS: Simcere gets exclusive rights to innovative influenza drug
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced Tuesday that it has signed a deal giving it exclusive commercialization rights for treatment of influenza indications using the innovative drug ADC189 from Jiaxing…
FAST NEWS: Simcere’s revenue jumps on rising innovative drug sales
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) said on Thursday it expects to report its revenue grew between 24% and 26.3% to between 3.35 billion yuan ($468 million) and 3.41 billion yuan in…
Drug maker Junshi seeks Swiss cure for cash woes
The biotech aims to raise 3.4 billion yuan through Swiss GDRs in its second major fund-raising push in just over six months Key Takeaways: Junshi Biosciences reported dismal results in…
Missing the Covid boat, Junshi stumbles back to old business
Despite developing an oral drug to treat Covid, the biotech company's revenue fell sharply and its net loss widened by nearly 40% in the first quarter Key Takeaways: Junshi Bioscience's…
FAST NEWS: Kintor Pharma hits new low as loss keeps growing
The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced on Thursday it did not record any revenue last year, as its net loss widened 13.3% to 954 million yuan ($139 million) from 842 million…
Recent Articles
Drug maker Junshi seeks Swiss cure for cash woes
1877.HK
688150.SHG
Missing the Covid boat, Junshi stumbles back to old business
1877.HK
688180.SHG
RELATED ARTICLES
-
FAST NEWS: Simcere’s revenue jumps on rising innovative drug sales
2096.HK
-
CStone breaks up with drugs partner as U.S. rollout stalls
2616.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
FAST NEWS: Simcere gets exclusive rights to innovative influenza drug
2096.HK
-
BeiGene goes for global growth with sales and R&D push
BGNE.US 6160.HK
-
Everest reaches new heights on growing drug sales
1952.HK
- InSilico seeks IPO boost to get AI drugs over the line
